Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients

Critical Care Medicine

Volumn 39, Issue 3, 2011, Pages 480-488

  Jabaudon, Matthieu ^a   Futier, Emmanuel ^a   Roszyk, Laurence ^a   Chalus, Elodie ^a   Guerin, Renaud ^a   Petit, Antoine ^a   Mrozek, Segolene ^a   Perbet, Sebastien ^a   Cayot Constantin, Sophie ^a   Chartier, Christian ^a   Sapin, Vincent ^a   Bazin, Jean Etienne ^a   Constantin, Jean Michel ^a  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

acute lung injury; acute respiratory distress syndrome; biomarker; intensive care unit; receptor for advanced glycation end products; severe sepsis

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR;

ACUTE LUNG INJURY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; ARTIFICIAL VENTILATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE SEVERITY; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; SEPTIC SHOCK;

EID: 79952187875     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318206b3ca     Document Type: Article

References (40)

1. Rubenfeld GD, Caldwell E, Peabody E, et al: Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353:1685-1693. (Pubitemid 41464707)
2. Bernard GR, Artigas A, Brigham KL, et al: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149(3 Pt 1):818-824. (Pubitemid 24082248)
3. Bierhaus A, Humpert PM, Morcos M, et al: Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 2005; 83:876-886. (Pubitemid 41598688)
4. Schmidt AM, Yan SD, Yan SF, et al: The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001; 108:949-955. (Pubitemid 32946067)
5. Fehrenbach H, Kasper M, Tschernig T, et al: Receptor for advanced glycation endproducts (RAGE) exhibits highly differential cellular and subcellular localisation in rat and human lung. Cell Mol Biol (Noisy-le-grand) 1998; 44:1147-1157.
6. Shirasawa M, Fujiwara N, Hirabayashi S, et al: Receptor for advanced glycation endproducts is a marker of type I lung alveolar cells. Genes Cells 2004; 9:165-174. (Pubitemid 38312960)
7. Mukherjee TK, Mukhopadhyay S, Hoidal JR: Implication of receptor for advanced glycation end product (RAGE) in pulmonary health and pathophysiology. Respir Physiol Neurobiol 2008; 162:210-215.
8. Raucci A, Cugusi S, Antonelli A, et al: A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membranebound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J 2008; 22:3716-3727.
9. Zhang L, Bukulin M, Kojro E, et al: Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases. J Biol Chem 2008; 283: 35507-35516.
10. Cheng C, Tsuneyama K, Kominami R, et al: Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs. Mod Pathol 2005; 18: 1385-1396. (Pubitemid 41348659)
11. Uchida T, Shirasawa M, Ware LB, et al: Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 2006; 173:1008-1015.
12. Calfee CS, Ware LB, Eisner MD, et al: Plasma receptor for advanced glycation end-products and clinical outcomes in acute lung injury. Thorax 2008; 63:1083-1089.
13. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342: 1301-1308.
14. Chavakis T, Bierhaus A, Nawroth PP: RAGE (receptor for advanced glycation end products): A central player in the inflammatory response. Microbes Infect 2004; 6:1219-1225. (Pubitemid 39370091)
15. Van Zoelen MA, Achouiti A, Schmidt AM, et al: Ligands of the receptor for advanced glycation end products, including high-mobility group box 1, limit bacterial dissemination during Escherichia coli peritonitis. Crit Care Med 2010; 38:1414-1422.
16. Bopp C, Hofer S, Weitz J, et al: sRAGE is elevated in septic patients and associated with patients outcome. J Surg Res 2008; 147: 79-83. (Pubitemid 351626081)
17. American College of Chest Physicians/ Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874.
18. Dellinger RP, Levy MM, Carlet JM, et al: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327.
19. Malbouisson LM, Muller JC, Constantin JM, et al: Computed tomography assessment of positive end-expiratory pressure-induced alveolar recruitment in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2001; 163:1444-1450. (Pubitemid 32506614)
20. Puybasset L, Cluzel P, Gusman P, et al: Regional distribution of gas and tissue in acute respiratory distress syndrome. I. Consequences for lung morphology. CT Scan ARDS Study Group. Intensive Care Med 2000; 26:857-869. (Pubitemid 30616038)
21. Rouby JJ, Puybasset L, Cluzel P, et al: Regional distribution of gas and tissue in acute respiratory distress syndrome. II. Physiological correlations and definition of an ARDS Severity Score. CT Scan ARDS Study Group. Intensive Care Med 2000; 26:1046-1056.
22. Puybasset L, Gusman P, Muller JC, et al: Regional distribution of gas and tissue in acute respiratory distress syndrome. III. Consequences for the effects of positive endexpiratory pressure. CT Scan ARDS Study Group. Adult Respiratory Distress Syndrome. Intensive Care Med 2000; 26:1215-1227.
23. Constantin JM, Cayot-Constantin S, Roszyk L, et al: Response to recruitment maneuver influences net alveolar fluid clearance in acute respiratory distress syndrome. Anesthesiology 2007; 106:944-951. (Pubitemid 46684060)
24. Matthay MA, Wiener-Kronish JP: Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis 1990; 142(6 Pt 1):1250-1257.
25. Frank JA, Briot R, Lee JW, et al: Physiological and biochemical markers of alveolar epithelial barrier dysfunction in perfused human lungs. Am J Physiol Lung Cell Mol Physiol 2007; 293:L52-L59. (Pubitemid 47080706)
26. Briot R, Frank JA, Uchida T, et al: Elevated levels of the receptor for advanced glycation end products, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fluid clearance in isolated perfused human lungs. Chest 2009; 135:269-275.
27. Neeper M, Schmidt AM, Brett J, et al: Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 1992; 267:14998-15004.
28. Schmidt AM, Vianna M, Gerlach M, et al: Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem 1992; 267:14987-14997.
29. Chavakis T, Bierhaus A, Al-Fakhri N, et al: The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: A novel pathway for inflammatory cell recruitment. J Exp Med 2003; 198:1507-1515. (Pubitemid 37467165)
30. Puybasset L, Cluzel P, Chao N, et al: A computed tomography scan assessment of regional lung volume in acute lung injury. The CT Scan ARDS Study Group. Am J Respir Crit Care Med 1998; 158(5 Pt 1): 1644-1655.
31. Lu Q, Constantin JM, Nieszkowska A, et al: Measurement of alveolar derecruitment in patients with acute lung injury: Computerized tomography versus pressure-volume curve. Crit Care 2006; 10:R95.
32. Sternberg DI, Gowda R, Mehra D, et al: Blockade of receptor for advanced glycation end product attenuates pulmonary reperfusion injury in mice. J Thorac Cardiovasc Surg 2008; 136:1576-1585.
33. Zhang H, Tasaka S, Shiraishi Y, et al: Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury. Am J Respir Crit Care Med 2008; 178:356-362.
34. Queisser MA, Kouri FM, Konigshoff M, et al: Loss of RAGE in pulmonary fibrosis: Molecular relations to functional changes in pulmonary cell types. Am J Respir Cell Mol Biol 2008; 39:337-345.
35. Englert JM, Hanford LE, Kaminski N, et al: A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. Am J Pathol 2008; 172:583-591. (Pubitemid 351354532)
36. Reynolds PR, Schmitt RE, Kasteler SD, et al: Receptors for advanced glycation endproducts (RAGE) targeting protect against hyperoxia-induced lung injury in mice. Am J Respir Cell Mol Biol 2010; 42: 545-551.
37. Santilli F, Vazzana N, Bucciarelli LG, et al: Soluble forms of RAGE in human diseases: Clinical and therapeutical implications. Curr Med Chem 2009; 16:940-952.
38. Creagh-Brown BC, Quinlan GJ, Evans TW: RAGE inhibition: Healthy or harmful? Crit Care Med 2010; 38:1487-1490.
39. Schmidt AM, Yan SD, Yan SF, et al: The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta 2000; 1498(2-3):99-111.
40. Ramasamy R, Yan SF, Schmidt AM: RAGE: Therapeutic target and biomarker of the in- flammatory response-The evidence mounts. J Leukoc Biol 2009; 86:505-512